Search for: "Watson v. Target Corporation" Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Apr 2024, 9:01 pm by renholding
Every day, we see individuals, corporations, analysts, and others touting these developments. [read post]
10 Nov 2019, 4:38 pm by INFORRM
The leading phone hacking campaigner and Labour Deputy Leader Tom Watson MP has announced that he is standing down as an MP. [read post]
27 Jul 2011, 1:01 am by Marie Louise
  Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
14 Nov 2011, 12:48 am by INFORRM
On the UK Constitutional Law blog Paul Bernal examines website blocking in light of the recent case Twentieth Century Fox Film Corporation & Ors v British Telecommunications [2011] EWHC 2714 (Ch). [read post]
29 Jan 2012, 4:07 pm by INFORRM
This is reported to be as a result of information supplied by the News Corporation Management and Standards Committee. [read post]
11 Mar 2018, 5:30 pm by INFORRM
 Labour Culture spokesman Tom Watson said, that in the light of this evidence, the Government should reopen the Leveson Inquiry. [read post]
11 Aug 2014, 4:24 am by Ben
 Automated Solutions Corporation v. [read post]
23 Apr 2018, 1:20 am by Kevin LaCroix
Supreme Court issued its unanimous decision in Cyan, Inc. v. [read post]
15 May 2019, 7:21 pm
Social credit itself refers generally to a new mode of data-driven governance through which data analytics are used to create and operate algorithms that provide a basis for rewards and punishments for targeted behaviors. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]